Key statistics
On Monday, Lupin Ltd (LUPIN:NSI) closed at 2,303.10, -2.80% below its 52-week high of 2,369.50, set on Mar 06, 2026.
52-week range
| Open | 2,310.00 |
|---|---|
| High | 2,319.90 |
| Low | 2,284.40 |
| Bid | -- |
| Offer | -- |
| Previous close | 2,330.00 |
| Average volume | 1.06m |
|---|---|
| Shares outstanding | 457.04m |
| Free float | 242.05m |
| P/E (TTM) | 21.58 |
| Market cap | 1.07tn INR |
| EPS (TTM) | 108.62 INR |
| Annual div (ADY) | 12.00 INR |
|---|---|
| Annual div yield (ADY) | 0.52% |
| Div ex-date | Jul 25 2025 |
| Div pay-date | Sep 10 2025 |
Data delayed at least 15 minutes, as of Mar 09 2026 10:00 BST.
More ▼
- Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
- Lupin Announces the Approval and Launch of Brivaracetam Oral Solution in the United States
- 'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
- 'Made in India - The story of Desh Bandhu Gupta, Lupin and Indian Pharma' Book Launched in Mumbai
- Lupin Launches Topiramate Extended-Release Capsules in the United States
- Lupin Launches Dasatinib Tablets in the United States
More ▼
